Bob Seeman, Founder, Chairman and CEO
T 416-923-8540
F 416-352-5071
W www.clera.com
Clera was founded in 2001 to commercialize the ground-breaking central nervous system (CNS) research of Dr. Philip Seeman. Dr. Seeman’s 40 years of receptor-based research forms the foundation of Clera’s drug discovery & development pipeline targeting major CNS markets including schizophrenia/psychosis, Parkinson’s Disease, and depression.